Alnylam Pharmaceuticals Inc (ALNY)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

675 WEST KENDALL STREET CAMBRIDGE, MA 02142

Operates a biopharmaceutical company seeking to develop and commercialize new drugs that work through a recently discovered system in cells known as RNA interference (RNAi). Initial programs are focused on an eye disease (macular degeneration) and lung disease (respiratory syncytial virus).

Data as of 2021-05-08 10:28:55 -0400
Market Cap15.434 Billion Shares Outstanding117.545 Million Avg 30-day Volume511.145 Thousand
P/E Ratio-17.61128 Dividend Yield EPS-7.55
Price/Sales27.03 Debt to Equity3.51 EBITDA-764.774 Million
Price to Book Value16.66 Forward PE-20.61 Enterprise Value13.916 Billion
Total Cash1.71 Billion Current Debt494.825 Million Gross Profit475.131 Million
BETA0.81432 52-week High/Low178.41 / 119.29 Next Earnings Date2021-07-29 Price to Cash FLow (P/CF) -67.3543
Data provided by IEX Cloud
View SEC Filings from ALNY instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 6 7 -14.29% 2 (0.12%) 4 (0.25%) -50.0%
Funds Holding: 364 346 5.2% 86 (5.17%) 81 (5.04%) 6.17%
13F shares: 107.863 Million 107.262 Million 0.56% 25.057 Million 24.945 Million 0.45%
% Ownership 92.8402 92.3232 0.56% 21.5674 21.4706 0.45%
New Positions: 57 31 83.87% 22 9 144.44%
Increased Positions 125 121 3.31% 34 30 13.33%
Closed Positions 36 48 -25.0% 16 18 -11.11%
Reduced Positions 119 128 -7.03% 24 29 -17.24%
Total Calls 1.004 Million 902.44 Thousand 11.25% 393.6 Thousand 375.8 Thousand 4.74%
Total Puts 933.561 Thousand 866.871 Thousand 7.69% 342.557 Thousand 317.257 Thousand 7.97%
PUT/CALL Ratio 0.93 0.96 -3.12% 0.87 0.84 3.57%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Alnylam Pharmaceuticals Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding ALNY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALNY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

6.4 Thousand total shares from 8 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARAGANORE JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 217,898 2021-04-19 6

VAISHNAW AKSHAY PRESIDENT, R&D

  • Officer
 14,634 2021-04-19 5

KEATING LAURIE EVP, CHIEF LEGAL OFFICER

  • Officer
 7,300 2021-04-19 6

GREENSTREET YVONNE PRESIDENT & COO

  • Officer
 11,430 2021-04-19 6

TANGULER TOLGA EVP, CHIEF COMMERCIAL OFFICER

  • Officer
 0 2021-03-09 1

POULTON JEFFREY V. CHIEF FINANCIAL OFFICER

  • Officer
 23,200 2021-02-24 1

PAUL STEVEN M

  • Director
 1,000 2020-12-18 2

SHARP PHILLIP A

  • Director
 266,899 2020-12-07 3

GREENE BARRY E PRESIDENT

  • Officer
 73,501 2020-09-09 3

FANUCCI MARSHA

  • Director
 0 2020-07-01 1

AUSIELLO DENNIS A

  • Director
 0 2020-07-01 1

SCHULMAN AMY W

  • Director
 0 2020-07-01 1

BONNEY MICHAEL W

  • Director
 0 2020-07-01 1

PYOTT DAVID E I

  • Director
 0 2020-07-01 1

REITAN COLLEEN F

  • Director
 0 2020-07-01 1

HAMBURG MARGARET A

  • Director
 0 2020-07-01 1

BRANDICOURT OLIVIER

  • Director
 0 2020-03-02 0

SCHIMMEL PAUL

  • Director
 0 2019-07-01 0

SONI MANMEET SINGH CHIEF FINANCIAL OFFICER

  • Officer
 0 2019-02-28 0

SANOFI

  • 10% Owner
 0 2019-01-17 0

MASON MICHAEL VP, FINANCE AND TREASURER

  • Officer
 0 2018-09-27 0

CLARKE JOHN K

  • Director
 0 2018-06-20 0

STARR KEVIN P

  • Director
 0 2017-06-02 0

GROS DAVID-ALEXANDRE C SVP, CHIEF BUSINESS OFFICER

  • Officer
 0 2016-12-20 0

REID LAURENCE SVP, CHIEF BUSINESS OFFICER

  • Officer
 No longer subject to file 2014-12-31 0

DZAU VICTOR J

  • Director
 0 2013-06-06 0

NOVARTIS AG

NOVARTIS PHARMA AG

  • 10% Owner
 No longer subject to file 2012-09-20 0

ALLEN PATRICIA L VP OF FINANCE AND TREASURER

  • Officer
 1,165 2010-12-08 0

KOBLAN KENNETH S CHIEF SCIENTIFIC OFFICER

  • Officer
 357 2010-12-08 0

VINCENT JAMES L

  • Director
 0 2010-06-17 0

SATO VICKI L

  • Director
 0 2010-06-02 0

SCOLNICK EDWARD M

  • Director
 0 2009-06-11 0

SCHMIDT JOHN A JR SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
 0 2008-12-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2021-04-21 18:22:42 -0400 2021-04-21 S 1,892 $136.84 d 14,756 direct yes -0.7621 1.3936 4.1809 5 -0.7621 2

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2021-04-21 18:22:42 -0400 2021-04-21 S 107 $138.48 d 14,119 direct yes -0.7621 1.3936 4.1809 5 -0.7621 2

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2021-04-21 18:22:42 -0400 2021-04-21 S 203 $135.41 d 16,648 direct yes -0.7621 1.3936 4.1809 5 -0.7621 2

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2021-04-21 18:22:42 -0400 2021-04-21 S 530 $137.60 d 14,226 direct yes -0.7621 1.3936 4.1809 5 -0.7621 2

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2021-04-21 18:22:42 -0400 2021-04-20 F 2,266 $131.75 d 16,936 direct -0.7621 1.3936 4.1809 5 -0.7621 2

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-21 18:20:57 -0400 2021-04-20 F 270 $134.62 d 214,765 direct -0.7621 1.3936 4.1809 5 -0.7621 2

KEATING LAURIE - Officer EVP, CHIEF LEGAL OFFICER

2021-04-21 18:21:20 -0400 2021-04-20 F 75 $134.42 d 6,866 direct -0.7621 1.3936 4.1809 5 -0.7621 2

GREENSTREET YVONNE - Officer PRESIDENT & COO

2021-04-21 18:21:44 -0400 2021-04-20 F 85 $134.49 d 11,023 direct -0.7621 1.3936 4.1809 5 -0.7621 2

POULTON JEFFREY V. - Officer CHIEF FINANCIAL OFFICER

2021-04-21 18:22:36 -0400 2021-04-20 F 50 $134.49 d 3,135 direct -0.7621 1.3936 4.1809 5 -0.7621 2

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-21 18:20:57 -0400 2021-04-20 F 7,237 $131.75 d 215,035 direct -0.7621 1.3936 4.1809 5 -0.7621 2

KEATING LAURIE - Officer EVP, CHIEF LEGAL OFFICER

2021-04-21 18:21:20 -0400 2021-04-20 F 2,014 $131.75 d 6,941 direct -0.7621 1.3936 4.1809 5 -0.7621 2

GREENSTREET YVONNE - Officer PRESIDENT & COO

2021-04-21 18:21:44 -0400 2021-04-20 F 2,266 $131.75 d 11,108 direct -0.7621 1.3936 4.1809 5 -0.7621 2

POULTON JEFFREY V. - Officer CHIEF FINANCIAL OFFICER

2021-04-21 18:22:36 -0400 2021-04-20 F 1,333 $131.75 d 3,185 direct -0.7621 1.3936 4.1809 5 -0.7621 2

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2021-04-21 18:22:42 -0400 2021-04-20 F 85 $134.56 d 16,851 direct -0.7621 1.3936 4.1809 5 -0.7621 2

KEATING LAURIE - Officer EVP, CHIEF LEGAL OFFICER

2021-04-21 18:21:20 -0400 2021-04-19 A 4,518 a 8,955 direct -0.7621 1.3936 4.1809 5 -0.7621 2

GREENSTREET YVONNE - Officer PRESIDENT & COO

2021-04-21 18:21:44 -0400 2021-04-19 A 5,083 a 13,374 direct -0.7621 1.3936 4.1809 5 -0.7621 2

POULTON JEFFREY V. - Officer CHIEF FINANCIAL OFFICER

2021-04-21 18:22:36 -0400 2021-04-19 A 4,518 a 4,518 direct -0.7621 1.3936 4.1809 5 -0.7621 2

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2021-04-21 18:22:42 -0400 2021-04-19 S 989 $137.60 d 20,241 direct yes -0.7621 1.3936 4.1809 5 -0.7621 2

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2021-04-21 18:22:42 -0400 2021-04-19 S 417 $140.02 d 19,202 direct yes -0.7621 1.3936 4.1809 5 -0.7621 2

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2021-04-21 18:22:42 -0400 2021-04-19 S 1,678 $136.76 d 21,230 direct yes -0.7621 1.3936 4.1809 5 -0.7621 2

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2021-04-21 18:22:42 -0400 2021-04-19 S 622 $138.64 d 19,619 direct yes -0.7621 1.3936 4.1809 5 -0.7621 2

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2021-04-21 18:22:42 -0400 2021-04-19 A 5,083 a 22,908 direct -0.7621 1.3936 4.1809 5 -0.7621 2

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-21 18:20:57 -0400 2021-04-19 A 16,236 a 222,272 direct -0.7621 1.3936 4.1809 5 -0.7621 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 22:15:03 UTC -0.2338 0.2838 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 21:45:03 UTC -0.2338 0.2838 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 21:15:03 UTC -0.2338 0.2838 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 20:45:03 UTC -0.2338 0.2838 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 20:15:03 UTC -0.2338 0.2838 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 19:45:03 UTC -0.2338 0.2838 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 19:15:02 UTC -0.2338 0.2838 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 18:45:02 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 18:15:03 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 17:45:03 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 17:15:04 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 16:45:04 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 16:15:04 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 15:45:03 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 15:15:03 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 14:45:03 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 14:15:03 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 13:45:04 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 13:15:04 UTC -0.2 0.25 3200000
ALNYLAM PHARMACEUTICALS INC ALNY 2021-05-11 12:45:03 UTC -0.2 0.25 3200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund ALNY -5145.0 shares, $-668695.65 2020-12-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund ALNY -5162.0 shares, $-670905.14 2020-12-31 N-PORT
AQR Funds- AQR Multi-Asset Fund ALNY -350.0 shares, $-45489.5 2020-12-31 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund ALNY -25.0 shares, $-3640.0 2020-09-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund ALNY -430.0 shares, $-55887.1 2020-12-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund ALNY -598.0 shares, $-48091.16 2019-09-30 N-PORT
FundVantage Trust- Gotham Master Neutral Fund ALNY -8.0 shares, $-1164.8 2020-09-30 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund ALNY -1330.0 shares, $-172860.1 2020-12-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund ALNY -1153.0 shares, $-149855.41 2020-12-31 N-PORT
PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments ALNY -2258.0 shares, $-339783.84 2021-01-31 N-PORT
SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund ALNY -351.0 shares, $-52818.48 2021-01-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- 361 Global Long/Short Equity Fund ALNY -21325.0 shares, $-3208986.0 2021-01-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund ALNY -2591.0 shares, $-389893.68 2021-01-31 N-PORT
Nuveen Investment Trust II- Nuveen Equity Long/Short Fund ALNY -3700.0 shares, $-547970.0 2021-02-28 N-PORT

Elevate your investments